EUVIMEDEUVIMED entdecken
Crossref

Heterogeneity and Regulatory Mechanisms of ALK-Mutant and Wild-Type Epithelial Cells in Non-Small-Cell Lung Cancer: Single-Cell Transcriptomics and Chromatin Accessibility

Yafu Zhou, Manni Yi, Jianhua Yan, Huiguo Chen, Jingsong Yang

Pharmacology · 12.03.2026 · 1-21

DOI: 10.1159/000550967 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology, online erschienen am 12.03.2026. Verfasst von Yafu Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cardiothoracic Surgery Department, Hunan Provincial People's Hospital, The First-Affiliated Hospital of Hunan Normal University, Changsha, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Anaplastic Lymphoma Kinase, Epithelial Cells. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Anaplastic lymphoma kinase (ALK) mutations are key oncogenic drivers in non-small-cell lung cancer (NSCLC). Although ALK tyrosine kinase inhibitors (TKIs) elicit high initial response rates, relapse due to acquired resistance is common. Conventional approaches fail to resolve tumor heterogeneity and epigenetic control, necessitating multi-omic integration to dissect molecular differences between ALK-mutant and wild-type (WT) tumors.

Methods

Single-cell RNA sequencing (scRNA-seq) and matched chromatin accessibility (scATAC-seq) data of 5 WT and 4 ALK-mutant NSCLC samples from GEO (GSE274934) were integrated. “Seurat” and “Harmony” packages in R were used for data preprocessing and batch correction. “Monocle” package reconstructed epithelial differentiation trajectories. “CellChat” package delineated cell-cell communication. “Signac” package integrated multiple omics data and analyzed the differentially accessible chromatin regions. Motif enrichment based on the JASPAR database identified key transcription factors. The role of CEACAM6 in the malignant progression of ALK-mutant-mutant NSCLC was assessed by qRT-PCR, CCK-8, colony formation, and wound-healing assays.

Results

ALK-mutant epithelial cells exhibit disrupted differentiation trajectories, characterized by loss of SPINK1 expression and pan-expression of MARCKSL1. ALK-mutant cells relied on CEACAM5/6 signaling for communication; WT cells primarily engaged in multidirectional MIF interactions. ALK-mutant cells showed increased global chromatin accessibility. Motif analysis revealed enrichment of polycomb repressive complex (PRC) pathway components and EGR1 binding sites (survival/drug resistance-associated) in ALK-mutant cells, whereas WT cells specifically enriched KLF5, ZNF148, and GLIS3 motifs. In vitro, CEACAM6 expression was significantly upregulated in ALK-mutant compared to WT cells. CEACAM6 knockdown significantly inhibited cell proliferation and migration, and reduced p-AKT and EGR1 protein levels, indicating that CEACAM6 promotes malignant progression of ALK-mutant NSCLC through the AKT-EGR1 signaling axis.

Conclusion

ALK mutations drive tumor stemness and drug resistance by blocking epithelial cell differentiation, activating CEACAM6-mediated signaling, enhancing chromatin accessibility, and remodeling the EGR1/PRC regulatory network. Targeting CEACAM6 and its downstream effector EGR1 may represent an effective strategy to overcome ALK-TKI resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsAnaplastic Lymphoma KinaseEpithelial CellsChromatinHumansMutationTranscriptomeSingle-Cell Gene Expression AnalysisGene Expression Regulation, NeoplasticCell Line, TumorSingle-Cell Analysis

Stichwörter der Autor:innen

ALK mutationATAC-seqChromatin accessibilityNon-small-cell lung cancerSingle-cell transcriptome

Substanzen

Anaplastic Lymphoma KinaseALK protein, humanChromatin

Autor:innen und Institutionen

  • Cardiothoracic Surgery Department, Hunan Provincial People's Hospital, The First-Affiliated Hospital of Hunan Normal University, Changsha, China.
  • Operating Theatre Department, Hunan Provincial People's Hospital, The First-Affiliated Hospital of Hunan Normal University, Changsha, China.
  • Cardiothoracic Surgery Department, Hunan Provincial People's Hospital, The First-Affiliated Hospital of Hunan Normal University, Changsha, China, yangjingsong_yjs@163.com.

Zitieren

APA

Zhou, Y., Yi, M., Yan, J., Chen, H., & Yang, J. (2026). Heterogeneity and Regulatory Mechanisms of ALK-Mutant and Wild-Type Epithelial Cells in Non-Small-Cell Lung Cancer: Single-Cell Transcriptomics and Chromatin Accessibility. Pharmacology, 1-21. https://doi.org/10.1159/000550967

Vancouver

Zhou Y, Yi M, Yan J, Chen H, Yang J. Heterogeneity and Regulatory Mechanisms of ALK-Mutant and Wild-Type Epithelial Cells in Non-Small-Cell Lung Cancer: Single-Cell Transcriptomics and Chromatin Accessibility. Pharmacology. 2026:1-21. doi:10.1159/000550967

BibTeX
@article{Zhou2026,
  author = {Zhou, Yafu and Yi, Manni and Yan, Jianhua and Chen, Huiguo and Yang, Jingsong},
  title = {Heterogeneity and Regulatory Mechanisms of ALK-Mutant and Wild-Type Epithelial Cells in Non-Small-Cell Lung Cancer: Single-Cell Transcriptomics and Chromatin Accessibility},
  journal = {Pharmacology},
  year = {2026},
  pages = {1--21},
  doi = {10.1159/000550967}
}
Kostenlos starten →